Evidence map›Paper›PMID 32914088›Full record

ArticleJournal of translational genetics and genomics2020

Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.

Bridget E Bax

Open access · diamondAbstract read
In one paragraph

Article in Journal of translational genetics and genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Advances in Management of Mitochondrial Myopathies.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Literature Review on Health Emigration in Rare Diseases-A Machine Learning Perspective.International journal of environmental research and public health · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Bridget E BaxInstitute of Molecular and Clinical Sciences, St. George's University of London, London, SW17 ORE, UK.
St George's, University of London · GB

Funding

Medical Research Council G0902179Medical Research Council MR/K025406/1
6 · The paper itself

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an ultra-rare disease caused by mutations in

Indexed as

mitochondrial diseasemitochondrial DNAMitochondrial neurogastrointestinal encephalomyopathyMNGIEthymidine phosphorylaseTYMP

Identifiers

PMID32914088
PMCPMC7116056
OpenAlexW3010885632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.